3 Healthcare REITs Raised Their 2026 Outlooks as Senior Housing Demand Grows
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Healthcare REITs are getting a demographic tailwind that works independently of interest rates. Ventas (NYSE:VTR) Chairman and CEO Debra Cafaro put it plainly this summer: “Demographic demand is strong and getting stronger as the baby boomers begin turning 80 this year. Meanwhile, new supply remains at historic lows.”[1] All three REITs below beat expectations in the third quarter and raised full-year 2026 FFO guidance. For retirees, that matters because FFO is the cash earnings stream that pays the dividend. Yields range from modest to above 6%, so each case rests on how well the payout is covered.
Welltower: Smallest Yield, Strongest Senior Housing Engine
Welltower (NYSE:WELL) pays a quarterly dividend of $0.85, or $3.40 annualized. At the November 19 close of $243.19, that works out to a forward yield of about 1.4%. Welltower’s income appeal rests on dividend growth.
Dividend safety: Welltower raised full-year normalized FFO guidance to $6.47 to $6.53 per share[2], a midpoint of $6.50. The annualized dividend uses roughly 52% of that midpoint, which leaves plenty of room. Net debt to adjusted EBITDA is 3.02x, up from 2.36x a year ago because of acquisition spending, but still low for a REIT. The record has a gap, though. Welltower cut its quarterly payout from $0.87 to $0.61 in 2020 and held it there through 2023. It has since raised it to $0.67 in 2024, $0.74 in 2025, and $0.85 in 2026, a 15% increase. The November payment was its 222nd consecutive quarterly cash dividend[2], but the payout is still below the $0.87 it paid before the cut.
Bull case: Same-store NOI in its senior housing operating (SHO) portfolio rose 21.0%[2], the 16th consecutive quarter[3] of growth above 20%. SHO occupancy reached 90.2%[2], and 93.5% of residents pay privately, so government reimbursement policy has little effect on revenue. CEO Shankh Mitra told analysts, “We have never seen a better pricing environment than we see today.”[3] Analysts rate the stock 6 Strong Buy, 13 Buy and 3 Hold, with an average target of $265.45.
Risk: The shares trade at roughly 37x the FFO guidance midpoint, so a lot of execution is already in the price. The communities Welltower bought in the third quarter averaged just 66%[3] occupancy. Its $21.0B[2] of investments so far this year need to fill up as planned to justify that valuation.
Healthpeak Properties: Monthly Ultra-High-Yield Income With Three Growth Levers
Healthpeak Properties (NYSE:DOC) pays $0.10167 per share every month, or $1.22004 annualized. At $19.19, the forward yield is about 6.4%, which makes it the only ultra-high-yield name on this list (if a monthly paycheck is the goal, we rounded up seven more names that pay every 30 days in a free report here). The December dividend is payable December 30, 2026,[4] to holders of record on December 18.
Dividend safety: Management raised 2026 FFO as Adjusted guidance to $1.76 to $1.78 per share[4], its third[5] increase this year. The dividend uses about 69% of the midpoint, a thinner cushion than its peers have but still solid. Net debt to adjusted EBITDA is 4.7x[5], and liquidity was about $3.8 billion as of October 30. Income investors should know the history. Healthpeak cut its quarterly dividend from $0.575 to $0.37 in 2016 and to $0.30 in 2021. In 2025, it changed its payment schedule, replacing a quarterly $0.305 payment with a monthly $0.10167 payment. That move changed the payment timing while keeping the payout amount essentially the same.
Bull case: Healthpeak owns three kinds of healthcare property. Senior housing, held through its 69%[5] stake in Janus Living, grew same-store NOI 25.9%[4]. Outpatient medical rose 3.1%[4] on 846,000 square feet[5] of quarterly leasing. CEO Scott Brinker said, “Our outpatient business is stronger than ever, and we expect internal growth to accelerate in 2027 given our recent lease executions and pipeline.”[5] Lab occupancy improved 130 basis points during the quarter to 79.8%. At about 11x the FFO midpoint, it is the cheapest of the three.
Risk: Interest rates. Healthpeak has $1.4 billion[5] of debt maturing in 2027 that currently costs about 3%, below today’s market rates. Interest expense was already rising, reaching $92.3 million[6] in the second quarter versus $75.1 million a year earlier. Refinancing that debt at higher rates would cut into the coverage the monthly dividend relies on.
Ventas: Improving Balance Sheet Behind a Growing Payout
Ventas pays $0.52 quarterly, or $2.08 annualized. At $87.00, the forward yield is about 2.4%.
Dividend safety: Normalized FFO guidance rose to $3.87 to $3.90[7], a midpoint of $3.89. The dividend uses roughly 53% of that figure. Ventas has improved its leverage the most of the three: net debt to further adjusted EBITDA fell to 4.4x[7] from 5.3x, which management called its strongest level in well over a decade. Liquidity is $4.5 billion[8]. Ventas cut its quarterly payout from $0.7925 to $0.45 in 2020 and held it flat through 2024. It then raised it to $0.48 in 2025 and to $0.52 in 2026, an increase of about 8.3%.
Bull case: Same-store cash NOI in its senior housing operating portfolio (SHOP) rose 16%[7], or 17% in the U.S. That marks the 17th consecutive quarter[8] of double-digit SHOP NOI growth. Average occupancy climbed 290 bps[7] year over year. Ventas has closed $5.2B[7] of senior housing investments this year at expected first-year yields of 6.6%[8]. Cafaro expects the U.S. senior population to grow 28% over the next five years[8]. Analysts rate it 5 Strong Buy, 14 Buy and 4 Hold, with an average target of $99.77. The stock trades at about 22x the FFO midpoint.
Risk: Ventas pays for much of its growth by issuing new shares. It has settled 47.3M shares for $3.9B of equity forward proceeds this year, with $0.8B still unsettled. If profitable deals become harder to find, those extra shares will hold back FFO per share and, with it, the pace of dividend raises.
Which Healthcare REIT Fits Your Income Plan
All three REITs benefit from the same aging population, but they serve different income goals. Healthpeak gives retirees the most current income, paid monthly, at the lowest valuation. Ventas offers a growing dividend backed by the fastest-improving balance sheet. Welltower has the lowest payout as a share of FFO and the strongest senior housing growth. Over the next few months, watch senior housing occupancy, Healthpeak’s 2027 refinancing, and the 2027 dividend announcements.
Contact [email protected] for any questions or corrections.








